CIK 0001719406 · Non-accelerated filer<br>Smaller reporting company
NRX Pharmaceuticals, Inc.
Sign in to watch- Ticker
- NRXP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 822844431
- Phone
- 484-254-6134
- Business address
- 1201 ORANGE STREET, SUITE 600, WILMINGTON, DE, 19801
- Former names
- Big Rock Partners Acquisition Corp.
- 424B3 Offering Prospectus
- EFFECT Other Notice of Effectiveness
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
- POS EX Other Post-effective Amendment
- POS EX Other Post-effective Amendment
- S-1 Offering Registration Statement
- 424B3 Offering Prospectus
- 424B3 Offering Prospectus
- 10-K Report Annual Report
- 3 Insider Initial Statement of Ownership
- 424B3 Offering Prospectus
- 424B3 Offering Prospectus
- 8-K Event Executive or director change · Other events
- 4 Derivatives Options or other derivatives
- 424B3 Offering Prospectus
- 424B3 Offering Prospectus
- 8-K Event Executive or director change · Other events
- 424B3 Offering Prospectus
- 424B3 Offering Prospectus
Page 13 of 24 · 479 filings